INGN

SEC source: 0001209191-22-016017 · doc4.xml · derivative · entry 1

Glezer Stanislav · CIK 0001866861 · EVP, Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,360

Underlying: Common Stock · 11,360 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F2 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date.

F2 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date.

SEC source: 0001209191-22-016012 · doc4.xml · derivative · entry 7

Shabshab Nabil · CIK 0001568903 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,051

Underlying: Common Stock · 39,051 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F7 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date.

F7 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date.

SEC source: 0001209191-22-016012 · doc4.xml · derivative · entry 6

Shabshab Nabil · CIK 0001568903 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,936

Underlying: Common Stock · 16,936 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F6 · derivative.exercise_date: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years.

F6 · derivative.expiration_date: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years.

SEC source: 0001209191-22-016012 · doc4.xml · derivative · entry 5

Shabshab Nabil · CIK 0001568903 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,114

Underlying: Common Stock · 4,705 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F5 · derivative.exercise_date: Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years.

F5 · derivative.expiration_date: Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years.

SEC source: 0001209191-22-016012 · doc4.xml · nonDerivative · entry 4

Shabshab Nabil · CIK 0001568903 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,655

F3 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2022.

SEC source: 0001209191-22-016012 · doc4.xml · nonDerivative · entry 3

Shabshab Nabil · CIK 0001568903 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,385

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-22-016012 · doc4.xml · nonDerivative · entry 2

Shabshab Nabil · CIK 0001568903 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,744

F2 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with the 2021 performance-based restricted stock award granted on March 1, 2021 and vested on March 1, 2022.

SEC source: 0001209191-22-016012 · doc4.xml · nonDerivative · entry 1

Shabshab Nabil · CIK 0001568903 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,409

F1 · shares: The reported securities represent shares earned and vested on March 1, 2022 based on achievement of the financial performance conditions for the 2021 fiscal year that were approved as part of the 2021 performance-based restricted stock award granted on March 1, 2021.

SEC source: 0001209191-22-016015 · doc4.xml · derivative · entry 1

Parr George J · CIK 0001722045 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,360

Underlying: Common Stock · 11,360 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F2 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

F2 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

SEC source: 0001209191-22-003266 · doc4.xml · derivative · entry 2

McFarland Loren L · CIK 0001292280 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,083 shares

Expires 2023-10-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Subject to reporting person's continuing to be a Service Provider, 1/12th of the total shares subject to the option shall vest on the first day of each month following the vesting commencement date. The vesting commencement date for this option is October 1, 2013.

SEC source: 0001209191-22-003266 · doc4.xml · nonDerivative · entry 1

McFarland Loren L · CIK 0001292280 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,191

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-067953 · doc4.xml · derivative · entry 3

Sanford Bart Ben · CIK 0001751365 · EVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,457

Underlying: Common Stock · 273 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F3 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.

F3 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.

SEC source: 0001209191-21-067953 · doc4.xml · nonDerivative · entry 2

Sanford Bart Ben · CIK 0001751365 · EVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,879

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2021.

SEC source: 0001209191-21-067953 · doc4.xml · nonDerivative · entry 1

Sanford Bart Ben · CIK 0001751365 · EVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,104

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-067951 · doc4.xml · derivative · entry 3

Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,915

Underlying: Common Stock · 546 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F4 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month, subject to the reporting person continuing to be a service provider through each such vesting date.

F4 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month, subject to the reporting person continuing to be a service provider through each such vesting date.

SEC source: 0001209191-21-067951 · doc4.xml · nonDerivative · entry 2

Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,902

F2 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2021.

F1 · balance_after: Shares beneficially owned are 30,155 shares more than the previously filed Form 4s due to an error reporting the shares owned on December 15, 2020. An amendment to the original Form 4 has been filed to correct the error.

SEC source: 0001209191-21-067951 · doc4.xml · nonDerivative · entry 1

Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,392

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Shares beneficially owned are 30,155 shares more than the previously filed Form 4s due to an error reporting the shares owned on December 15, 2020. An amendment to the original Form 4 has been filed to correct the error.

SEC source: 0001209191-21-058304 · doc4.xml · derivative · entry 3

Taylor Brenton · CIK 0001596103 · EVP, Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,945 shares

Expires 2022-03-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is May 1, 2012.

SEC source: 0001209191-21-058304 · doc4.xml · nonDerivative · entry 1

Taylor Brenton · CIK 0001596103 · EVP, Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,735

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-056662 · doc4.xml · derivative · entry 3

Huggenberger Raymond · CIK 0001596078 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,806

Underlying: Common Stock · 4,000 shares

Expires 2022-05-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option was May 1, 2015.

SEC source: 0001209191-21-056662 · doc4.xml · nonDerivative · entry 2

Huggenberger Raymond · CIK 0001596078 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,583

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.

SEC source: 0001209191-21-056662 · doc4.xml · nonDerivative · entry 1

Huggenberger Raymond · CIK 0001596078 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,583

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-054885 · doc4.xml · derivative · entry 5

Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,461

Underlying: Common Stock · 546 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F5 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.

F5 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.

SEC source: 0001209191-21-054885 · doc4.xml · derivative · entry 4

Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 253 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F4 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2018, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month, subject to the reporting person continuing to be a service provider through each such vesting date.

F4 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2018, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month, subject to the reporting person continuing to be a service provider through each such vesting date.

SEC source: 0001209191-21-054885 · doc4.xml · nonDerivative · entry 3

Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,691

F2 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2021.

F1 · balance_after: Shares beneficially owned are 271 shares less than the previously filed Form 4s due to an error reporting the shares withheld to cover the Reporting Person's tax withholding liability on June 1, 2021. An amendment to the original Form 4 has been filed to correct the error.

SEC source: 0001209191-21-054885 · doc4.xml · nonDerivative · entry 2

Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,307

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Shares beneficially owned are 271 shares less than the previously filed Form 4s due to an error reporting the shares withheld to cover the Reporting Person's tax withholding liability on June 1, 2021. An amendment to the original Form 4 has been filed to correct the error.

SEC source: 0001209191-21-054885 · doc4.xml · nonDerivative · entry 1

Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,761

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Shares beneficially owned are 271 shares less than the previously filed Form 4s due to an error reporting the shares withheld to cover the Reporting Person's tax withholding liability on June 1, 2021. An amendment to the original Form 4 has been filed to correct the error.

SEC source: 0001209191-21-054772 · doc4.xml · derivative · entry 4

Taylor Brenton · CIK 0001596103 · EVP, Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,730

Underlying: Common Stock · 273 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F3 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.

F3 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.

SEC source: 0001209191-21-054772 · doc4.xml · nonDerivative · entry 2

Taylor Brenton · CIK 0001596103 · EVP, Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,790

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2021.

SEC source: 0001209191-21-054772 · doc4.xml · nonDerivative · entry 1

Taylor Brenton · CIK 0001596103 · EVP, Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,135

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-054770 · doc4.xml · derivative · entry 3

Sanford Bart Ben · CIK 0001751365 · EVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,730

Underlying: Common Stock · 273 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F3 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.

F3 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.

SEC source: 0001209191-21-054770 · doc4.xml · nonDerivative · entry 2

Sanford Bart Ben · CIK 0001751365 · EVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,831

F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2021.

SEC source: 0001209191-21-054770 · doc4.xml · nonDerivative · entry 1

Sanford Bart Ben · CIK 0001751365 · EVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,056

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-052418 · doc4.xml · derivative · entry 7

Huggenberger Raymond · CIK 0001596078 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,594 shares

Expires 2022-05-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015.

F6 · balance_after: The reported shares were granted as a single stock option and initially reported as a single line item on the Form 4 dated 05/15/2015 reporting the option grant. In subsequent Form 4s the option was split into a NSO portion and an ISO portion, each of which has been reported as a separate line item.

SEC source: 0001209191-21-052418 · doc4.xml · derivative · entry 6

Huggenberger Raymond · CIK 0001596078 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,806

Underlying: Common Stock · 4,000 shares

Expires 2022-05-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015.

F6 · balance_after: The reported shares were granted as a single stock option and initially reported as a single line item on the Form 4 dated 05/15/2015 reporting the option grant. In subsequent Form 4s the option was split into a NSO portion and an ISO portion, each of which has been reported as a separate line item.

SEC source: 0001209191-21-052418 · doc4.xml · nonDerivative · entry 5

Huggenberger Raymond · CIK 0001596078 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,583

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.

F4 · price: Represents the weighted average share price of an aggregate total of 2,604 shares sold in the price range of $63.00 to $63.41 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-21-052418 · doc4.xml · nonDerivative · entry 4

Huggenberger Raymond · CIK 0001596078 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,187

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.

F3 · price: Represents the weighted average share price of an aggregate total of 2,990 shares sold in the price range of $62.00 to $62.99 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-21-052418 · doc4.xml · nonDerivative · entry 3

Huggenberger Raymond · CIK 0001596078 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,177

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.

F2 · price: Represents the weighted average share price of an aggregate total of 1,000 shares sold in the price range of $60.93 to $61.91 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-21-052418 · doc4.xml · nonDerivative · entry 2

Huggenberger Raymond · CIK 0001596078 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,177

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-052418 · doc4.xml · nonDerivative · entry 1

Huggenberger Raymond · CIK 0001596078 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,583

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-050763 · doc4.xml · derivative · entry 1

Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,223

Underlying: Common Stock · 9,223 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F2 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.

F2 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.

SEC source: 0001209191-21-050762 · doc4.xml · derivative · entry 1

Glezer Stanislav · CIK 0001866861 · EVP, Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,298

Underlying: Common Stock · 12,298 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F2 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.

F2 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.

SEC source: 0001209191-21-049484 · doc4.xml · derivative · entry 6

Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,895

Underlying: Common Stock · 1,397 shares

Expires 2022-05-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015.

SEC source: 0001209191-21-049484 · doc4.xml · nonDerivative · entry 4

Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,779

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2020.

F3 · price: Represents the weighted average share price of an aggregate total of 1,397 shares sold in the price range of $80.12 to $80.68 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-21-049484 · doc4.xml · nonDerivative · entry 3

Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,176

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-049484 · doc4.xml · derivative · entry 5

Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,292

Underlying: Common Stock · 8,235 shares

Expires 2022-05-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015.

SEC source: 0001209191-21-049484 · doc4.xml · nonDerivative · entry 2

Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,779

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2020.

F2 · price: Represents the weighted average share price of an aggregate total of 8,235 shares sold in the price range of $80.00 to $80.16 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-21-049484 · doc4.xml · nonDerivative · entry 1

Bauerlein Alison · CIK 0001596080 · EVP, Finance, & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,014

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-048497 · doc4.xml · derivative · entry 4

Taylor Brenton · CIK 0001596103 · EVP, Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,303

Underlying: Common Stock · 7,942 shares

Expires 2022-05-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015.

SEC source: 0001209191-21-048497 · doc4.xml · nonDerivative · entry 2

Taylor Brenton · CIK 0001596103 · EVP, Engineering

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,862

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2020.

F2 · price: Represents the weighted average share price of an aggregate total of 7,942 shares sold in the price range of $75.00 to $75.24 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.